[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Wed, Mar 30th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Tue, Mar 29th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
[ Mon, Mar 28th 2022 ]: WOPRAI
Chris Howerton Maintained (AXSM) at Strong Buy with Increased Target to $77 on, Mar 29th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Chris Howerton of Jefferies, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Increased Target from $71 to $77 on, Mar 29th, 2022.
Chris has made no other calls on AXSM in the last 4 months.
There is 1 other peer that has a rating on AXSM. Out of the 1 peers that are also analyzing AXSM, 0 agree with Chris's Rating of Hold.
This is the rating of the analyst that currently disagrees with Chris
- Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $50 on, Wednesday, March 2nd, 2022